Satisfaction with treatment doesn’t necessarily affect whether people with myasthenia gravis (MG) take their medications as directed, according to a new study that surveyed nearly 100 patients at a center in China. Findings also indicate that people living with MG who are older are less likely to take their…
News
Researchers called for standardized guidelines for diagnosing and treating people with myasthenia gravis (MG) who test negative for typical disease-driving antibodies. A review study showed that antibody-negative MG tends to manifest earlier than antibody-positive disease, and a substantial portion of antibody-negative patients do not respond adequately to standard immune-suppressing…
Ongoing symptoms that persist despite treatment can disrupt daily life, work, and mental well-being among adults with generalized myasthenia gravis (gMG), according to the BEYOND study. When study participants rated how strongly they agreed with statements about how these ongoing symptoms affect their everyday lives, the statement — “If…
Biologic therapies were associated with less steroid use and greater muscle strength than treatment with standard care among people recovering from a myasthenic crisis, a potentially life-threatening complication of myasthenia gravis (MG), a new study from China suggests. Data showed that six months after leaving the hospital, individuals…
The Myasthenia Gravis News forums welcomed Jenny McCue, vice president of research and clinical development at the Myasthenia Gravis Foundation of America (MGFA), for an hour-long Q&A earlier this month. Forum members had an opportunity to ask questions in real time about the latest in myasthenia gravis…
Most neurologists believe that CAR T-cell treatments have the potential to revolutionize care for neuro-immune diseases such as myasthenia gravis (MG), but hopes are tempered by still-unanswered questions about their safety and long-term impact. That’s according to a survey of 92 neurologists in the U.S. conducted last month by…
Myasthenia gravis (MG) can have a substantial impact on a person’s quality of life, but currently available data make it hard to nail down a number that can represent the average impact of the disease in standard health economic models, a review study showed. Score estimates in the EuroQol…
Adults with late-onset myasthenia gravis (LOMG), when symptoms begin at age 50 or later, showed advanced fatty replacement of the thymus gland, while a separate group of LOMG patients showed reduced production of new immune cells, according to a new study. Abnormalities in the thymus gland are well established…
Myasthenia gravis (MG) is associated with substantial disruptions to employment, with only about half of working-age adults with MG in a Spanish study employed and nearly one-third receiving permanent work disability benefits. Among participants who reported how MG had affected their employment, more than four in 10 said they…
Myasthenia gravis (MG) may be driven by antibody-producing immune B-cells going rogue in the thymus gland and developing escape mechanisms that allow them to attack the body’s own healthy tissues, according to new research by U.S. scientists. “Our study suggests there’s more to myasthenia gravis than antibodies alone,” Ankit…
Recent Posts
- How an MG diagnosis changed our lives forever
- Bionews survey finds positive and negative emotions coexist in MG
- MDA Engage: National ambassador brings message of belonging, resilience
- gMG treatments show varied benefits across response measures
- Like a donkey, my MG body is stubborn, but it has also carried me